Results 291 to 300 of about 406,081 (396)
ESC Heart Failure, Volume 12, Issue 3, Page 2125-2133, June 2025.Abstract Background Sodium glucose cotransporter 2 inhibitors (SGLT2i) represent one of the four pillars of heart failure (HF) pharmacological therapy. Objective The study aims to clarify SGLT2i antiarrhythmic effect on patients with HF with reduced ejection fraction (HFrEF) in terms of atrial and ventricular arrhythmias (AAs and VAs) reduction ...
Marco Valerio Mariani +17 more
wiley +1 more source
ESC Heart Failure, Volume 12, Issue 3, Page 2190-2199, June 2025.In this retrospective, observational study of a real‐life cohort of patients with heart failure with reduced ejection fraction, long‐term survival was improved in patients who achieved sustained reverse remodeling. Greater increases in ejection fraction (EF) and reductions in left ventricular end‐systolic diameter at the time of EF recovery, greater ...
Silas Ramos Furquim +13 more
wiley +1 more source
Clinical and Electrophysiological Predictors of Isthmus Dependency in Atrial Flutter. [PDF]
Diagnostics (Basel)Katov L +8 more
europepmc +1 more source
ESC Heart Failure, Volume 12, Issue 3, Page 2267-2277, June 2025.Abstract Background Atrial secondary mitral valve regurgitation (ASMR) is a distinct anatomical subset of secondary mitral regurgitation (SMR). Evidence of the effect of transcatheter edge‐to‐edge repair (TEER) on left atrial (LA) anatomy and function, especially reverse remodelling (LARR), is still sparse.
Aniela Petrescu +10 more
wiley +1 more source
Pulmonary Edema After Cardioversion for Paroxysmal Atrial Flutter
, 2000 Nobuhiko Kobayashi +5 more
openalex +2 more sources
International Journal of Cancer, Volume 156, Issue 11, Page 2158-2168, 1 June 2025.What's new? Pirtobrutinib, a highly selective, noncovalent (reversible) Bruton tyrosine kinase inhibitor (BTKi), has shown promise in treating patients with B‐cell malignancies following treatment with covalent BTKis. However, potential geographic and ethnic differences in patient response to pirtobrutinib remain to be clarified.
Yanyan Liu +13 more
wiley +1 more source
eJHaem, Volume 6, Issue 3, June 2025.ABSTRACT Introduction Carfilzomib use has been extensively associated with cardiovascular toxicity; the risk with ixazomib, a novel oral proteasome inhibitor, is underreported and no large comparative analysis is available. Methods We conducted a retrospective cohort study utilizing the TriNetX platform to compare toxicity outcomes among multiple ...
Benjamin J. Lee +6 more
wiley +1 more source
The “16‐gram window” of contact‐force: A new criterion for very high‐power short‐duration ablation
Journal of Arrhythmia, Volume 41, Issue 3, June 2025.A lower but also a higher mean contact‐force was associated with suboptimal vHPSD applications. Hence, a “16‐gram window” of contact‐force, from 6 to 22 g, could optimize energy application in vHPSD ablation. Abstract Background Very high‐power short‐duration (vHPSD) ablation with the novel QDOT™ catheter allows the regulation of target temperature by ...
Dimitrios Bismpos +9 more
wiley +1 more source